Sanofi has begun promoting Acomplia to doctors even though it is not yet approved by the FDA—kinda, sorta. What’s actually happening is that part of Sanofi’s diabetes sales force is briefing docs on “cardiometabolic risk, intra-abdominal adiposity and the endo-cannabinoid system.” (Those are posh med school words that mean “fat people.”)
According to a copy of a detail piece that a source kindly sent me (see download below), “increased activity of the endocannabinoid system has been shown to have an effect on: food intake, energy expenditure, and regulation of body weight.”
If only Sanofi had a drug that could regulate the endocannabinoid system. Sigh.
Oh, wait! It does! It’s called Acomplia! (Or maybe it’s called Zimulti?) Fancy that! What an amazing coincidence! According to this Sanofi press release, “Acomplia acts to decrease the overactivity of the endocannabinoid system”!
Of course, because Acomplia is not yet approved in the U.S. Sanofi sales reps aren’t allowed to mention the words “Acomplia,” “Zimulti” or “Rimonabant.” The drug goes before the FDA in June. Clearly, the Sanofites think they’ve got it right this time around, having been stalled at the FDA for some months.
The issues causing headaches for Sanofi right now: Whether the FDA will give them an indication for “obesity management,” (which likely won’t be reimbursed by insurance companies), “metabolic syndrome” (meaning a package of symptoms including intractable obesity that insurance companies would be likely to reimbuirse for), or Type 2 diabetes (which would definitely be covered).
Acomplia Report is predicting it will get obesity management only. Sanofi was expecting Acomplia to be a blockbuster, but such an unreimbursible indication would put a severe crimp on sales if patients have to pay for it themselves.
Some thoughts on pre-approval promotions: The FDA clearly prohibits companies from touting a drug that is unapproved by the FDA. But it doesn’t prohibit them from discussing diseases and conditions generally, even if the only reason they’re talking about such a disease is that they have an upcoming pill for it.
From a layperson’s perspective, then, unbranded pre-approval promotions are identical to promoting “misbranded” (to use the FDA’s technical term) unapproved drugs, with the two exceptions that the promotion takes place before, rather than after, approval and that the name of the drug is not used. Seems like its walking on the legal line ... a technical difference is not the same as an ethical one ...
Such pre-approval detailing is common, a source tells me, and indicates that the company believes it is between 6 and 2 months from receiving an “approved” letter from the feds.
Perhaps Sanofi has developed some good answers regarding concerns that Acomplia makes its users depressed and anxious.
Acomplia (Rimonabant) is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Acomplia (Rimonabant) has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges, such as smoking. - http://acomplia.weightloss.lt
Posted by: acomplia | January 17, 2008 at 07:42 AM
Acomplia (Rimonabant / Zimulti) is the new weight loss medication breakthrough from Sanofi-Aventis , exceeding Phentermine in it’s ability to help you lose the weight!
http://www.nordmed.com/acomplia-brand-medication.php
It is a CB1 cannabinoid receptor antagonist ,and Its main avenue of effect is reduction in appetite. Acomplia acts by obstructing the receptors, which control the food intake and energy expenditure - Thus resulting in reduced appetite.
http://www.nordmed.com/generic-acomplia-medication.php
Posted by: acomplia online | July 19, 2008 at 04:19 AM
http://www.ipetitions.com/petition/buyacomplia/
BUy Acomplia Online here at cheap prices
Posted by: Acomplia Online | October 21, 2008 at 06:45 AM
Trade shows are a great way to advertise. All you need is an attractive exhibition stand to catch the attention of attendees.
Posted by: Banner Stands | September 29, 2009 at 07:30 PM
Interesting article I like to know more about this topic is a nice site and important to know.
Posted by: Generic viagra | October 27, 2009 at 03:00 PM
These kind of medicines can be pretty riski for our children.
Posted by: Caffeine Addiction | November 02, 2009 at 10:19 AM
Great post I want to know the benefits of this Promotion for Acomplia because I want to have but I need to know everythings.
Posted by: Internet Pharmacy | November 03, 2009 at 12:15 PM
Acomplia is is great medicine even used in ill children or adults.
Posted by: Buy Generic Viagra | November 05, 2009 at 08:19 AM
hello thanks for post this information about Sanofi Doing Pre-Launch Promotion for Acomplia (or Zimulti or Whatever It's Called This Week) I think that is information is very useful
Posted by: Generic Viagra | November 30, 2009 at 05:44 PM
hey buddy amazing blog about Sanofi Doing Pre-Launch Promotion for Acomplia (or Zimulti or Whatever It's Called This Week) this information is very useful!!
Posted by: Generic Viagra | December 03, 2009 at 08:26 AM
nice and important blog about Sanofi Doing Pre-Launch Promotion for Acomplia (or Zimulti or Whatever It's Called This Week) thanks for sharing!!
Posted by: generic caverta | December 16, 2009 at 11:39 AM
this crap really works ?
Posted by: buy viagra | January 11, 2010 at 03:58 PM
Sanofi got Sculptra on the US market claiming it was for lypotrophy caused by HIV drugs. The compasionate use clause allowed it in the US. Then they failed to report serious adverse events from the product as is documemnted in a September 2009 FDA inspection report. That was a one month after they obtained approval for cosmetic use partially because there were no adverse events reported. for more information go to www.sculptradamage.com
This product is physician skill dependent. If they dont read the instructions and inject it like a volume filler the patient will pay the price. If the product whose entire mode of action is to stimulate the immune system cause a robust response it can not be stopped even with steroids and the patient is disfigured. the hydrophobic crystalline poly l lactic acid is on a small percentage of the content of some resorbable sutures because the crystalline form is long lived in the body and adverse events occur sometimes more then a year after injection. Sanofi Adventis Dermik does not care as long as they can make some money.
Posted by: Deborah | April 18, 2010 at 06:33 PM
Mishaps are like knives that either serve us or cut us as we grasp them by the handle or blade. Do you understand?
Posted by: jordan 11 | August 03, 2010 at 03:07 AM
Sanofi Doing Pre-Launch Promotion for Acomplia (or Zimulti or Whatever It's Called This Week) <-- Wonderful!
Posted by: Truth about Abs | August 30, 2010 at 10:08 AM
It was an intermittent thing that was cropping up so I changed it to another link. It should work for you now. I hope you enjoy.now link my name to see something others,take care!
Posted by: jordan 13 | October 15, 2010 at 11:14 PM
Please could you advise me as to where I can purchase Accomplia/Rimonabant.
Thanks I look forward to hearing from you.
Posted by: acomplia | October 26, 2010 at 05:57 AM
Hello,
Your blog provide me great information about "Sanofi Doing Pre-Launch Promotion for Acomplia" really It's amazing.... I enjoyed it very much! Thanks very much for the share... Keep posting.....
Posted by: zenegra online | November 18, 2010 at 04:04 AM
Hello,
Your blog provide me great information about "Sanofi Doing Pre-Launch Promotion for Acomplia" really It's amazing.... I enjoyed it very much! Thanks very much for the share...Keep posting....
http://www.raymeds.com
Posted by: Sam | November 18, 2010 at 04:06 AM
Rimonabant was a promising new anti-obesity drug which was launched in 2006 in U.K, Germany and 40 other countries.
Posted by: Generic Acomplia | December 02, 2010 at 07:06 AM
Trade shows are a great way to advertise. All you need is an attractive exhibition stand to catch the attention of attendees.
Posted by: Payday Loan | December 06, 2010 at 01:20 AM
Hey, this is cool stuff, something worth my time. Good attempt. Quiet interesting way of narrating interesting stuff. I think you have spent a lot of time in researching as some of the facts were just so shocking and never heard of. I am speechless…
Posted by: cheap kamagra online | December 09, 2010 at 05:41 AM
wow great i have read many articles about this topic and everytime i learn something new i dont think it will ever stop always new info , Thanks for all of your hard work!
Posted by: fap turbo | December 10, 2010 at 05:11 AM
Great piece of article. It explains so much about the topic. I should say it is a detailed article. Talks about a variety of things - something which I never thought could exist. What I found different in your article is the way you have gone about to explain the topic in a simplistic way.
Posted by: Generic Viagra | December 18, 2010 at 01:13 AM
You have a great knowledge
of the subject.Thanks for sharing such an article where education of people
matters the most.Your way of expressing articles through words is excellent.he
way of expressing things is best and informative.Keep sharing articles like
this.A great article with best possible effects.I am great fan of your
blog.
Posted by: Online Generic Viagra | January 05, 2011 at 01:33 AM